Surgical Endoscopy

, Volume 21, Issue 1, pp 103–108

Laparoscopic versus open approach for solitary insulinoma

  • Antonio Sa Cunha
  • Cedric Beau
  • Alexandre Rault
  • Bogdan Catargi
  • Denis Collet
  • Bernard Masson
Original Article



In recent years, advances in laparoscopic techniques have allowed surgeons to treat pancreatic lesions laparoscopically. Insulinoma, the most prevalent pancreatic endocrine tumor, is mostly benign and curable with surgical resection. This study aimed to assess the results from laparoscopic resection (LG) of insulinomas and to compare them with the results from open surgery (OG).


From September 1999 to December 2005, 56 laparoscopic pancreatic resections were performed for selected patients, including 12 laparoscopic resections of insulinomas. The results were compared with those of patients who underwent open resection of insulinomas selected from the authors’ pancreatic database.


Three conversions to the open approach were required because of inability to identify the tumor. There were no deaths in either group, and the morbidity rates were 25% (3/12) for LG and 55% (5/9) for OG (nonsignificant difference). The pancreatic fistula rate after laparoscopic enucleation was statistically lower than after open enucleation (14% vs 100%; p = 0.015). The mean postoperative hospital stay was 13 ± 5.9 days for LG and 17.6 ± 7.5 days for OG (nonsignificant difference). After exclusion of the patients who underwent conversion to laparotomy, the mean postoperative hospital stay was 11.5 ± 5.8 days for LG and 17.6 ± 7.5 days for OG (p = 0.04).


This study demonstrates the feasibility and safety of laparoscopic resection of insulinomas. The laparoscopic approach was associated with a decrease in hospital stay and pancreatic fistula after enucleation. Preoperative localization tests and laparoscopic ultrasonography seem necessary to prevent conversion.


Laparoscopic enucleation Laparoscopic pancreatic resection Solitary insulinoma 


  1. 1.
    Catarci M, Gentileschi P, Papi C, Carrara A, Marrese R, Gaspari AL, et al. (2004) Evidence-based appraisal of antireflux fundoplication. Ann Surg 239(3): 325–37PubMedCrossRefGoogle Scholar
  2. 2.
    Senagore AJ (2005) Laparoscopic sigmoid colectomy for diverticular disease. Surg Clin North Am 85(1): 19–24, viiPubMedCrossRefGoogle Scholar
  3. 3.
    Khaitan L, Holzman MD (2002) Laparoscopic advances in general surgery. Jama 287(12): 1502–5PubMedCrossRefGoogle Scholar
  4. 4.
    Masson B, Sa-Cunha A, Laurent C, Rault A, Collet D (2003) [Laparoscopic pancreatectomy:report of 22 cases]. Ann Chir 128(7): 452–6PubMedCrossRefGoogle Scholar
  5. 5.
    Gagner M, Inabnet WB, Biertho L, Salky B (2004) [Laparoscopic pancreatectomy: a series of 22 patients]. Ann Chir 129(1): 2–7; discussion 8–10PubMedCrossRefGoogle Scholar
  6. 6.
    Fernandez-Cruz L, Saenz A, Astudillo E, Martinez I, Hoyos S, Pantoja JP, et al. (2002) Outcome of laparoscopic pancreatic surgery: endocrine and nonendocrine tumors. World J Surg 26(8): 1057–65PubMedCrossRefGoogle Scholar
  7. 7.
    Edwin B, Mala T, Mathisen O, Gladhaug I, Buanes T, Lunde OC, et al. (2004) Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc 18(3): 407–11PubMedCrossRefGoogle Scholar
  8. 8.
    Shimizu S, Tanaka M, Konomi H, Mizumoto K, Yamaguchi K (2004) Laparoscopic pancreatic surgery: current indications and surgical results. Surg Endosc 18(3): 402–6PubMedCrossRefGoogle Scholar
  9. 9.
    Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, et al. (2005) Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137(6): 597–605PubMedCrossRefGoogle Scholar
  10. 10.
    Park AE, Heniford BT (2002) Therapeutic laparoscopy of the pancreas. Ann Surg 236(2): 149–58PubMedCrossRefGoogle Scholar
  11. 11.
    Service FJ, McMahon MM, O’Brien PC, Ballard DJ (1991) Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66(7): 711–9PubMedGoogle Scholar
  12. 12.
    Finlayson E, Clark OH (2004) Surgical treatment of insulinomas. Surg Clin North Am 84(3): 775–85PubMedCrossRefGoogle Scholar
  13. 13.
    Assalia A, Gagner M (2004) Laparoscopic pancreatic surgery for islet cell tumors of the pancreas. World J Surg 28(12): 1239–47PubMedCrossRefGoogle Scholar
  14. 14.
    Ayav A, Bresler L, Brunaud L, Boissel P (2005) Laparoscopic approach for solitary insulinoma: a multicentre study. Langenbecks Arch Surg 390(2): 134–40PubMedCrossRefGoogle Scholar
  15. 15.
    Fernandez-Cruz L, Martinez I, Cesar-Borges G, Astudillo E, Orduna D, Halperin I, et al. (2005) Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1. J Gastrointest Surg 9(3): 381–8PubMedCrossRefGoogle Scholar
  16. 16.
    Berends FJ, Cuesta MA, Kazemier G, van Eijck CH, de Herder WW, van Muiswinkel JM, et al. (2000) Laparoscopic detection and resection of insulinomas. Surgery 128(3): 386–91PubMedCrossRefGoogle Scholar
  17. 17.
    Jaroszewski DE, Schlinkert RT, Thompson GB, Schlinkert DK (2004) Laparoscopic localization and resection of insulinomas. Arch Surg 139(3): 270–4PubMedCrossRefGoogle Scholar
  18. 18.
    Gagner M, Pomp A, Herrera MF (1996) Early experience with laparoscopic resections of islet cell tumors. Surgery 120(6): 1051–4PubMedCrossRefGoogle Scholar
  19. 19.
    Lo CY, Chan WF, Lo CM, Fan ST, Tam PK (2004) Surgical treatment of pancreatic insulinomas in the era of laparoscopy. Surg Endosc 18(2): 297–302PubMedCrossRefGoogle Scholar
  20. 20.
    Warshaw AL (1988) Conservation of the spleen with distal pancreatectomy. Arch Surg 123(5): 550–3PubMedGoogle Scholar
  21. 21.
    Lesurtel M, Cherqui D, Laurent A, Tayar C, Fagniez PL (2003) Laparoscopic versus open left lateral hepatic lobectomy: a case-control study. J Am Coll Surg 196(2): 236–42PubMedCrossRefGoogle Scholar
  22. 22.
    Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J (2003) Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg 90(4): 445–51PubMedCrossRefGoogle Scholar
  23. 23.
    Clinical Outcomes of Surgical Therapy Study Group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350(20): 2050–9CrossRefGoogle Scholar
  24. 24.
    Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, et al. (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 359(9325): 2224–9PubMedCrossRefGoogle Scholar
  25. 25.
    Rothmund M, Angelini L, Brunt LM, Farndon JR, Geelhoed G, Grama D, et al. (1990) Surgery for benign insulinoma: an international review. World J Surg 14(3): 393–8; discussion 398–9PubMedCrossRefGoogle Scholar
  26. 26.
    Mabrut JY, Lifante JC, Cherki S, Sin S, Berger N, Peix JL (2001) [Is preoperative localization of insulinomas necessary?]. Ann Chir 126(9): 850–6PubMedCrossRefGoogle Scholar
  27. 27.
    Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST (1997) Pancreatic insulinomas. A 15-year experience. Arch Surg 132(8): 926–30Google Scholar
  28. 28.
    Knaebel HP, Diener MK, Wente MN, Buchler MW, Seiler CM (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92(5): 539–46PubMedCrossRefGoogle Scholar
  29. 29.
    Buchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, et al. (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163(1): 125–30; discussion 130–1PubMedCrossRefGoogle Scholar
  30. 30.
    Friess H, Beger HG, Sulkowski U, Becker H, Hofbauer B, Dennler HJ, et al. (1995) Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82(9): 1270–3PubMedGoogle Scholar
  31. 31.
    Gouillat C, Chipponi J, Baulieux J, Partensky C, Saric J, Gayet B (2001) Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br J Surg 88(11): 1456–62PubMedCrossRefGoogle Scholar
  32. 32.
    Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, et al. (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226(5): 632–41PubMedCrossRefGoogle Scholar
  33. 33.
    Montorsi M, Zago M, Mosca F, Capussotti L, Zotti E, Ribotta G, et al. (1995) Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117(1): 26–31PubMedCrossRefGoogle Scholar
  34. 34.
    Pederzoli P, Bassi C, Falconi M, Camboni MG (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81(2): 265–9Google Scholar
  35. 35.
    Sarr MG (2003) The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196(4): 556–64; discussion 564–5; author reply 565PubMedCrossRefGoogle Scholar
  36. 36.
    Shan YS, Sy ED, Lin PW (2003) Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 27(6): 709–14PubMedCrossRefGoogle Scholar
  37. 37.
    Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM, Flamant Y, et al. (2004) Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg 139(3): 288–94; discussion 295PubMedCrossRefGoogle Scholar
  38. 38.
    Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232(3): 419–29PubMedCrossRefGoogle Scholar
  39. 39.
    Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ (2005) Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92(9): 1059–67PubMedCrossRefGoogle Scholar
  40. 40.
    Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA (2001) Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025–6. Arch Surg 136(9): 1020–5PubMedCrossRefGoogle Scholar
  41. 41.
    Hashimoto LA, Walsh RM (1999) Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189(4): 368–73PubMedCrossRefGoogle Scholar
  42. 42.
    Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. (2003) CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 181(4): 987–92PubMedGoogle Scholar
  43. 43.
    Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB (2000) Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 214(2): 483–90PubMedGoogle Scholar
  44. 44.
    Dolan JP, Norton JA (2000) Occult insulinoma. Br J Surg 87(4): 385–7PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Antonio Sa Cunha
    • 1
  • Cedric Beau
    • 1
  • Alexandre Rault
    • 1
  • Bogdan Catargi
    • 2
  • Denis Collet
    • 1
  • Bernard Masson
    • 1
  1. 1.Department of Digestive SurgeryChu BordeauxPessacFrance
  2. 2.Department of EndocrinologyChu BordeauxPessacFrance

Personalised recommendations